Waters Medical Systems LLC

Waters Medical Systems is a transplant technology company specializing in organ preservation and perfusion systems. The company manufactures the RM4® platform, a hypothermic oxygenated machine perfusion system designed to improve kidney transplant outcomes by maintaining organ viability for up to 24 hours. The RM4® features pulsatile pressure delivery mimicking physiological cardiac waveforms, active in-cassette oxygenation, dual-kidney capacity, and WiFi-enabled remote monitoring via the IGL-App. Waters also produces preservation solutions: the IGL® Pulsatile Perfusion Solution for machine perfusion of kidneys, IGL® Cold Storage Solution for kidney, liver, and pancreas preservation, and Celsior® cold storage solution for heart preservation. The IGL-App provides secure cloud-connected remote monitoring of critical perfusion parameters including flow rate, pressure, temperature, and time, enabling transplant teams to maintain oversight during organ transport and preparation. The company serves transplant centers globally with clinically validated technologies supported by peer-reviewed research demonstrating improved graft survival rates and reduced adverse events, particularly in donation after circulatory death (DCD) cases. Waters Medical Systems positions itself as a trusted partner in advanced transplantation technology with decades of research and clinical experience.